All Vaccinology articles – Page 3
-
NewsNew international research alliance to tackle Mpox epidemic in Africa
MpoxVax AFRIVAC is a new €1.3 million international consortium that aims to rapidly deploy technology and develop new knowledge to end the current Mpox outbreak in the Democratic Republic of Congo (DRC) and surrounding countries.
-
NewsBig data study finds RSV vaccine highly effective in protecting older adults
A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV (respiratory syncytial virus) vaccine. VISION Network researchers report that across the board these vaccines were highly effective in older adults, even those with immunocompromising conditions, during the 2023-24 ...
-
NewsMpox vaccine is safe and generates a robust antibody response in adolescents
A clinical trial of an mpox vaccine in adolescents found it was safe and generated an antibody response equivalent to that seen in adults, according to a planned interim analysis of study data.
-
NewsmRNA vaccines for disease outbreaks can be synthesized in less time with new technique
Researchers have developed an innovative synthesis technology capable of producing high purity, fully chemically synthesized mRNA, cutting out the slower enzyme reactions, which could lead to mitigation of future infections at a preliminary stage.
-
NewsHPV vaccination switch to 1-dose gender-neutral approach
Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modelling.
-
NewsSecond round of polio vaccination in the Gaza Strip aims to vaccinate over half a million children
The second round of an emergency polio vaccination campaign is scheduled to start on 14 October 2024 in Gaza, to vaccinate an estimated 591 700 children under ten years of age with a second dose of the novel oral polio vaccine type 2 (nOPV2) vaccine.
-
NewsBetter use of vaccines could reduce antibiotic use by 2.5 billion doses annually, says WHO
A new report finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR).
-
NewsBioengineer awarded $3.4M for project to end polio
Bioengineer Kevin McHugh has been awarded $3.4 million for a project to incorporate protection against poliomyelitis into the combination vaccine that protects against five common and dangerous childhood diseases.
-
NewsResearchers confront new US and global challenges in vaccinations of adults
Decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the barriers including increasing vaccine hesitancy and new clinical and public health challenges in vaccinations of U.S. adults.
-
NewsChild Health Day 2024: influenza vaccine protects children from infection and hospitalization
Spain’s influenza vaccination campaign for children aged 6-59 months during the 2023/24 season was effective in preventing acute respiratory infections and hospitalisation, as vaccination was recommended for this age group at the national level for the first time.
-
NewsThe Democratic Republic of the Congo kicks off mpox vaccination
The Democratic Republic of the Congo today kicked off mpox vaccination, adding a vital measure to complement the ongoing outbreak control efforts to halt the spread of the viral disease and save lives. Source: NIAID Colorized transmission electron micrograph of mpox virus particles (teal) cultivated and purified ...
-
NewsVaccinating the young can save the old in the Tropics
A model suggests that vaccinating children and teens against the flu can help protect the elderly in tropical countries.
-
NewsGetting the flu and then your shot may benefit immunity
In a new study, researchers have found that natural immunity from previous flu infections has a significant impact on how well future influenza vaccinations work.
-
News$12 million grant to research how vaccines induce lasting immunity
Researchers have received a $12 million grant to study how vaccines trigger long-lasting immune responses. The work may inform the design of new, more protective vaccines for respiratory viruses, including SARS-CoV-2 and influenza.
-
NewsMMR vaccine still best protection against measles - modelling study suggests level of protection decreases slightly over time
A new study shows the MMR vaccine remains the best protection against measles. The modelling study in England suggests level of protection decreases slightly over time.
-
NewsThousands of donkeys vaccinated against rabies
The Donkey Sanctuary is collaborating with local government agencies and partner organisations, to support vaccination programmes in two key communities that rely on donkeys for their livelihoods.
-
NewsResearchers home in on vaccine target in an ancient scourge
Researchers and doctors have collected one of the most extensive genomic surveys of the syphilis bacterium to date and correlated the genetic data with clinical information about the patients who provided the samples.
-
NewsTwo-dose schedule could make HIV vaccines more effective
Researchers have found that the first dose primes the immune system, helping it to generate a strong response to the second dose, a week later.
-
NewsCall for global gender-neutral HPV vaccination by 2030
A new global initiative is calling for a more ambitious, ethical and equitable approach that will see more boys and men gain access to cancer-preventing Human Papillomavirus (HPV) vaccination and protect more people worldwide from HPV-related cancers.
-
NewsResearchers investigate bunyaviruses and picornaviruses in bid to stave off next pandemic
A $13 million per year grant will enable researchers to accelerate their investigations of bunyaviruses, which include life-threatening respiratory and hemorrhagic fever viruses, and picornaviruses, notably enterovirus D68.
